The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vamousse Lice Treatment
Pediculicide · SODIUM CHLORIDE 2 [hp_X]/mL · Aerosol, Foam · Topical · Alliance Pharma Inc.
NDC 72238-0001-01 · 1 BOTTLE, WITH APPLICATOR in 1 BOX / 177 mL in 1 BOTTLE, WITH APPLICATOR · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Pediculicide (Aerosol, Foam)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alliance Pharma Inc. | SODIUM CHLORIDE 2 [hp_X]/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vamousse Lice Treatment — NDC 72238-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72238000101.
Free to cite with attribution — see how the data is put together.